Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Clinical Outcome Study for Dysferlinopathy

NCT01676077 is registered in ClinicalTrials.gov with Newcastle-upon-Tyne Hospitals NHS Trust as lead sponsor.

NCT NCT01676077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01676077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Clinical Outcome Study for Dysferlinopathy
Lead sponsor
Newcastle-upon-Tyne Hospitals NHS Trust
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2012
Completion date
March 31, 2024
Enrollment
200 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

dysferlinopathy, lgmd2b now classified as lgmdr2, miyoshi myopathy